Immediate Impact

1 by Nobel laureates 1 from Science/Nature 105 standout
Sub-graph 1 of 21

Citing Papers

Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
12 intermediate papers

Works of Daniel Newman being referenced

Performance of ELF Serum Markers in Predicting Fibrosis Stage in Pediatric Non-Alcoholic Fatty Liver Disease
2008

Author Peers

Author Last Decade Papers Cites
Daniel Newman 21 51 217 123 74 12 367
Craig Tenner 36 48 115 78 48 23 371
Rosemary French 21 45 105 110 59 9 309
Puthiery Va 50 24 125 51 36 10 338
Rhys Pockett 53 49 83 32 118 30 391
Ilya Golovaty 49 83 112 29 21 11 331
P Chou 20 43 137 74 53 17 388
E‐J Milne 3 36 156 157 86 21 407
Laura Holder 29 74 184 148 28 17 388
Deya Marzouk 45 39 77 70 105 19 357
Patrizia Künzler‐Heule 18 39 284 263 30 21 409

All Works

Loading papers...

Rankless by CCL
2026